Monoamine and iron-related toxicity: From 'serotonin-binding proteins' to lipid peroxidation and apoptosis in PC12 cells

General Pharmacology

Volumn 31, Issue 1, 1998, Pages 19-24

  Velez Pardo, Carlos ^a   Del Rio, Marlene Jimenez ^a   Ebinger, Guy ^b   Vauquelin, Georges ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Apoptosis; Iron; Lipid peroxidation; Monoamine; PC12; SBP

Indexed keywords

ASCORBIC ACID; BINDING PROTEIN; CALCIMYCIN; COPPER ION; DOPAMINE; EDETIC ACID; EGTAZIC ACID; FELODIPINE; IRON; MANGANESE; METAL; MONOAMINE; OXYGEN RADICAL; SEROTONIN; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; CATTLE; CELL STRAIN; CYTOTOXICITY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MONOAMINE METABOLISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REVIEW;

ANIMALS; APOPTOSIS; BIOGENIC MONOAMINES; CELL EXTRACTS; FREE RADICALS; IRON; LIPID PEROXIDATION; PC12 CELLS; RATS; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 0032125654     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00440-0     Document Type: Review

References (95)

1. ++ dependent protein kinase activity associated with serotonin binding protein. J. Neurochem. 49:1987;1105-1115.
2. Aznu S., Dhawan D., Singh N. Calcium ionophore A23187 induces apoptotic cell death in rat thymocytes. Cancer Lett. 107:1996;97-103.
3. Baffy G., Miyashita T., Williamson J.R., Reed J.C. Apoptosis induced by withdrawal of interlukin-3 (Il-3) from an IL-3-dependent hematopoeitic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem. 268:1993;6511-6519.
4. Barasch J.M., Tamir H., Nunez E.A., Gershon M.D. Serotonin-storing secretory granules from thyroid parafollicular cells. J. Neurosci. 7:1987;4017-4033.
5. Batistatou A., Green L. Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation. correlation with suppression of endonuclease activity J. Cell Biol. 115:1991;461-471.
6. 2+ concentration and DNA fragmentation. Cancer Res. 52:1992;1342-1346.
7. Ben-Shachar D., Youdim M.B.H. Intranigral iron injection induces behavioral and biochemical "Parkinsonism" in rats. J. Neurochem. 57:1991;2133-2135.
8. Ben-Shachar D., Zuk R., Glinka Y. Dopamine neurotoxicity. inhibition of mitochondrial respiration J. Neurochem. 64:1995;718-723.
9. Borchardt R.T. Affinity labelling of catechol O-methyltransferase by the oxidation products of 6-hydroxydopamine. Mol. Pharmac. 11:1975;436-449.
10. Brunmark A., Cadenas E. Redox and addition chemistry of quinoid compounds and its implications. Free Radical Biol. Med. 7:1989;435-477.
11. Cohen G., Heikkila R.E. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249:1974;2447-2452.
12. Cohen J.J., Duke R.C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132:1984;38-42.
13. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:1989;381-389.
14. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 114:1991;1953-1975.
15. Ebadi M., Srinivasan K.S., Baxi M.D. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48:1996;1-19.
16. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease. evidence supporting it Ann. Neurol. 32:1992;804-812.
17. Fishman J.B., Rubis J.B., Chen J.-C., Dickey B.F., Volicer L. Modification of brain guanine nucleotide-binding regulatory proteins by tryptamine-4,5-dione, a neurotoxic derivative of serotonin. J. Neurohem. 56:1991;1852-1854.
18. Floyd R.A., Wiseman B.B. Spin-trapping free radicals in the oxidation of 6-hydroxydopamine. Biochim. Biophys. Acta. 586:1979;196-207.
19. Gershon M.D., Tamir H. Release of endogeneous 5-hydroxytryptamine from resting and stimulated enteric neurons. Neuroscience. 6:1981;2277-2286.
20. Gershon M.D., Tamir H. Serotonectin and the family of proteins that bind serotonin. Biochem. Pharmac. 33:1984;3115-3118.
21. Gershon M.D., Liu K.P., Karpiak S.E., Tamir H. Storage of serotonin in vivo as a complex with serotonin binding protein in central and peripheral serotonergic neurons. J. Neurosci. 3:1983;1901-1911.
22. Glinka Y., Tipton K.F., Youdim M.B.H. Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J. Neurochem. 66:1996;2004-2010.
23. Golstein P., Ojcius D.M., Young J.D.-E. Cell death mechanism and the immune system. Immunol. Rev. 121:1991;29-65.
24. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., Richardson R.J. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology. 48:1997;650-658.
25. Goyal R.N., Garg D.K. Electro-oxidation of the neurotoxin 5,6-dihydroxytryptamine and effects of its oxidation products in mice. Bioelectrochem. Bioenerg. 39:1996;249-257.
26. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmac. 14:1978;633-643.
27. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73:1978;2424-2428.
28. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
29. Halliwell B., Aruoma O.I. DNA damage by oxygen-derived species. its mechanism and measurement in mammalian systems FEBS Lett. 281:1991;9-19.
30. Hensley K., Butterfield D.A., Hall N., Cole P., Subramaniam R., Mark R., Mattson M.P., Markesbery W.R., Harris M.E., Aksenov M., Aksenova M., Wu J.F., Carney J.M. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide. Ann. N. Y. Acad. Sci. 786:1996;120-134.
31. Ito S., Kato T., Fujita K. Covalent binding of catechols to proteins through the sulphydryl group. Biochem. Pharmac. 37:1988;1707-1710.
32. Jenner P.G. Oxidative stress as a cause of Parkinson's disease. Hunter A.J., Clark M. Neurodegeration. 1992;1-20 Academic Press, London.
33. Jenner P., Pharms F.R., Olanow W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 47(Suppl. 3):1996;S161-S170.
34. Jimenez Del Rio M., Pinxteren J., De Potter W.P., Ebinger G., Vauquelin G. Serotonin-binding proteins in the bovine cerebral cortex. interaction with serotonin and catecholamines Eur. J. Pharmac. 225:1992;225-234.
35. Jimenez Del Rio M., Pinxteren J., De Potter W., Ebinger G., Vauquelin G. Serotonin binding proteins in bovine retina. binding of serotonin and catecholamines Neurochem. Int. 22:1993;111-119. a.
36. Jimenez Del Rio M., Velez-Pardo C., Pinxteren J., De Potter W., Ebinger G., Vauquelin G. Binding of serotonin and dopamine to "serotonin binding proteins" in bovine frontal cortex. evidence for iron- induced oxidative mechanisms Eur. J. Pharmac. 247:1993;11-21. b.
37. Jimenez Del Rio M., Velez-Pardo C., Pinxteren J., De Potter W., Ebinger G., Vauquelin G. Interaction of serotonin- and dopamine- related neurotoxins with "serotonin binding proteins" in bovine frontal cortex. Biochem. Pharmac. 48:1994;253-258.
38. 3H]serotonin and its binding protein from enteric neurons. Brain Res. 174:1979;55-69.
39. Kato T., Ito S., Fujita K. Tyrosinase-catalyzed binding of 3,4- dihydroxyfenylalanine with proteins through the sulfhydryl group. Biochim. Biophys. Acta. 881:1986;415-421.
40. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis. a basic biological phenomenon with wide-ranging implications in tissue kinetics Br. J. Cancer. 26:1972;239-257.
41. Kluck R.M., McDougall C.A., Harmon B.V., Halliday J.W. Calcium chelators induce apoptosis. evidence that raised intracellular ionised calcium is not essential for apoptosis Biochim Biophys. Acta. 1223:1994;247-254.
42. Kruman I.I., Gukovskaya A.S., Petrunyaka V.V., Beletsky I.P., Trepakova E.S. Apoptosis of murine BW5147 tymoma cells induced by cold shock. J. Cell Physiol. 153:1992;112-117.
43. Langston J.W., Irwin I., Ricaurte G.A. Neurotoxins, Parkinsonism and Parkinson's disease. Pharmac. Ther. 32:1987;19-49.
44. Lee S., Christakos S., Small M.B. Apoptosis and signal transduction. clues to a molecular mechanism Curr. Opin. Cell Biol. 5:1993;286-291.
45. 2+ are not required to trigger apoptosis in human leukaemia cells. Clin. Exp. Immunol. 87:1992;465-471.
46. Liu K.P., Gershon M.D., Tamir H. Identification, purification and characterization of two forms of serotonin binding protein from rat brain. J. Neurochem. 44:1985;1289-1301.
47. 3H]norepinephrine with particulate fractions of cells responsive to catecholamines. Mol. Pharmac. 10:1974;563-581.
48. Martin S.J., Green D.R., Cotter T. Dicing with death. dissecting the components of the apoptosis machinery TIBS. 19:1994;26-30.
49. McConkey D.J., Orrenius S. Signal transduction pathways to apoptosis. Trends Cell Biol. 4:1994;370-375.
50. McConkey D.J., Hartzell P., Nicotera P., Orrenius S. Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J. 3:1989;1843-1849.
51. McDonald E., Sirvio J. Neurotoxins as tools in lesioning experiments. Harvey A.L. Natural and Synthetic Neurotoxins. 1993;1-46 Academic Press, Oxford.
52. McGahon A. J., Martin S. J., Bissonnette R. P., Mahboubi A., Shi Y., Mogil R. J., Nishioka W. K. and Green D. R. (1995) The end of the (cell) line: methods for the study of apoptosis in vitro. In Methods in Cell Biology, vol. 46 Cell Death (Edited by Schwartz L. M. and Osborne B. A.), pp. 153-185. Academic Press, London.
53. McIntire W.S. Quinoproteins. FASEB J. 8:1994;513-521.
54. Michel P.P., Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26:1990;428-435.
55. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247:1972;3170-3175.
56. Mitzuno Y., Suzuki K., Ohta S. Post-mortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease. J. Neurol. Sci. 96:1990;49-57.
57. Mytilineou C., Han S.-H., Cohen G. Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J. Neurochem. 61:1993;1470-1478.
58. Oder W., Prayer L., Grimm G., Spatt J., Ferenci P., Kollegger H., Schneider B., Gangl A., Deeck L. Wilson's disease. evidence of subgroups derivated from clinical findings and brain lesions Neurology. 43:1993;120-124.
59. Ojcius D.M., Zychlinsky A., Zheng L.M., Young J.D.-E. Ionophore-induced apoptosis. role of DNA fragmetation and calcium fluxes Exp. Cell Res. 197:1991;43-49.
60. 2+ dependent mechanism of cytotoxicity and programmed cell death. Toxicol. Lett. 64(65):1992;357-364.
61. Owen A.D., Shapira A.H.V., Jenner P., Marsden C.D. Oxidative stress and Parkinson's disease. Ann. N. Y. Acad. Sci. 786:1996;217-223.
62. Pardo B., Mena M.A., Fahn S., Garcia de Yebenes J. Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line. Mov. Dis. 8:1993;278-284.
63. Perotti M., Toddei F., Mirabelli F., Vairetti M., Bellomo G., McConkey D.J., Orrenius S. Calcium-dependent DNA fragmentation in human synovial cells exposed to cold shock. FEBS Lett. 259:1990;331-334.
64. Pinxteren J., Jimenez Del Rio M., Velez-Pardo C., Ebinger G., Vauquelin G., De Potter W. Soluble serotonin and catecholamines binding proteins in the bovine adrenal medulla. Neurochem. Int. 23:1993;343-350.
65. 2+ and L-arginine/NADPH Ann. N. Y. Acad. Sci. 738:1994;141-152.
66. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B.H. Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J. Neurochem. 52:1989;515-520.
67. Rodriguez-Tarduchy G., Collins M., Lopez-Rivas A. Regulation of apoptosis in interleukin-3 dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J. 9:1990;2997-3002.
68. Saner A., Thoenen H. Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Mol. Pharmac. 7:1971;147-154.
69. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. 92:1995;1989-1993.
70. 3+- induced neurotoxicity of dopamine: prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase. Chem. Biol. Interact. 72, 309-324.
71. Sengstock G.J., Olanow C.W., Dunn A.J., Arendash G.W. Iron induced neurodegeneration of nigrostriatal neurons. Brain Res. Bull. 28:1992;645-649.
72. Sinhababu A.K., Borchardt R.T. Molecular mechanism of biological action of the serotonergic neurotoxin 5,7-dihydroxytryptamine. Neurochem. Int. 12:1988;273-284.
73. Sloot W.N., Van der Sluijs-Gelling A.J., Gramsbergen J.B.P. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus. J. Neurochem. 62:1994;205-216.
74. Small D.H., Wurtman R.W. Serotonin binds specifically and saturably to an actin-like protein isolated from rat brain synaptosomes. Proc. Natl. Acad. Sci. 81:1984;959-963.
75. 3H]serotonin to skeletal muscle actin. J. Neurochem. 45:1985;819-824.
76. Sofic E., Paulus W., Jellinger K., Riederer P., Youdim M.B.H. Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains. J. Neurochem. 56:1991;978-982.
77. Sofic E., Lange K.W., Jellinger K. Reduced and oxidised glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142:1992;128-130.
78. Tamir H., Huang Y.L. Binding of serotonin to soluble protein from synaptosomes. Life Sci. 14:1974;83-93.
79. Tamir H., Gershon M.D. Storage of serotonin and serotonin binding protein in synaptic vesicles. J. Neurochem. 33:1979;35-44.
80. Tamir H., Liu K.P. On the nature of the interaction between serotonin and serotonin binding protein. effect of nucleotides, ions and sulfhydryl reagents J. Neurochem. 38:1982;135-141.
81. Tamir H., Rapport M.M. Effects of neurotoxins in vitro on the binding of serotonin to serotonin binding protein. Ann. N. Y. Acad. Sci. 305:1978;85-95.
82. Tamir H., Liu K.P., Fayette R.F., Hsiung S., Adlersberg M., Nunez E.A., Gershon M.D. Human medullary thyroid carcinoma. characterization of serotonergic and neuronal properties of neuroectodermally derived cell line J. Neurosci. 9:1989;1199.
83. Tanaka M., Sotomatsu A., Kanai H., Hirai S. Dopa and dopamine cause cultured neuronal death in presence of iron. J. Neurol. Sci. 101:1991;198-203.
84. Toll L. High-afinity binding and inhibition of calcium transport in a clonal cell line. J. Biol. Chem. 257:1982;13189-13192.
85. 2+ in cell injury, necrosis and apoptosis. Curr. Opin. Cell Biol. 4:1992;227-232.
86. 2+-mediated binding of serotonin and dopamine to skeletal muscle actin. resemblance to serotonin binding proteins Eur. J. Pharmac. 288:1995;209-218. a.
87. Velez-Pardo C., Jimenez Del Rio M., Ebinger G. and Vauquelin G. (1995b) Manganese and copper promote the binding of dopamine to "serotonin binding proteins" in bovine frontal cortex. 26, 615-622.
88. Velez-Pardo C., Jimenez Del Rio M., Ebinger G., Vauquelin G. Redox cycling activity of monoamine-"serotonin binding protein" conjugates. Biochem. Pharmac. 51:1996;1521-1525.
89. Velez-Pardo C., Jimenez Del Rio M., Verschueren H., Ebinger G., Vauquelin G. Dopamine and iron induce apoptosis in PC12 cells. Toxicology. 80:1997;76-84.
90. Volicer L., Crino P. Involvement of free radicals in dementia of the Alzheimer's type. a hypothesis Neurol. Aging. 11:1990;567-571.
91. Ward R.J., Florence A.L., Baldwin D., Abiaka C., Roland F., Ramsey M.H., Dickson D.P.E., Peters T.J., Crichton R.R. Biochemical and biophysical investigations of the ferrocene-iron-loaded rat. an animal model of primary haemochromatosis Eur. J. Biochem. 202:1991;405-410.
92. Winkler H., Fischer-Colbrie R. and Weber A. (1981) Chemical neurotransmission 75 years. In (Edited by Stjarne L., Hedqvist P., Lagercrantz H. and Wennmalm A.), Academic Press, London.
93. Yoo S.H., Albanesi J.P., Jameson D.M. Fluorescence studies of nucleotide interactions with bovine adrenal chromogranin A. Biochem. Biophys. Acta. 1040:1992;66-70.
94. Zheng L., Zychlinsky A., Liu C.-C., Ojcius D.M., Zheng L.M., Young J.D.-E. Extracellular ATP as a trigger for apoptosis or programme cell death. J. Cell Biol. 112:1991;279-288.
95. Zilkhafalb R., Ziv I., Nardi N., Offen D., Melamed E., Barzilai A. Monoamine-induced apoptotic neuronal cell death. Cell. Mol. Neurobiol. 17:1997;101-118.